Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Osteosarcoma × Immunoglobulin G × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 11 Lung Neoplasms 10 Fallopian Tube Neoplasms 10 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Glioblastoma 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 4 Pancreatic Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Prostatic Neoplasms 2 Oligodendroglioma 2 Nasopharyngeal Carcinoma 2 Medulloblastoma 2 Gliosarcoma 2 Carcinoma, Neuroendocrine 2 Brenner Tumor 2 Adenocarcinoma of Lung 2 Vipoma 1 Uveal Melanoma 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1

Interventions

Ifosfamide 14 Doxorubicin 11 Methotrexate 10 Cisplatin 9 Filgrastim 8 Cyclophosphamide 8 Etoposide 7 Magnetic Resonance Spectroscopy 6 apatinib 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Phantoms, Imaging 5 Nivolumab 5 Neoadjuvant Therapy 5 Leucovorin 5 Gemcitabine 5 Radiotherapy 4 Nuclear Medicine Department, Hospital 4 Drug Therapy 4 Docetaxel 4 Biopsy 4 regorafenib 3 palbociclib 3 olaparib 3 mifamurtide 3 fludarabine 3 cixutumumab 3 camrelizumab 3 cabozantinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡